Oncolytic virus VRT106

DRUG2 trials

Sponsors

Guangdong Provincial People's Hospital, Xiangya Hospital of Central South University

Conditions

Pancreatic Cancer

Phase 1

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

RecruitingNCT06758544

Guangdong Provincial People's HospitalPancreatic Cancer

Start: 2025-03-17End: 2026-11-30Target: 18Updated: 2025-08-17

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

Not yet recruitingNCT06866977

Xiangya Hospital of Central South UniversityPancreatic Cancer

Start: 2025-03-12End: 2025-12-31Target: 10Updated: 2025-03-10